164 related articles for article (PubMed ID: 27277043)
21. Genotypic intratumoral heterogeneity in breast carcinoma with HER2/neu amplification: evaluation according to ASCO/CAP criteria.
Brunelli M; Manfrin E; Martignoni G; Miller K; Remo A; Reghellin D; Bersani S; Gobbo S; Eccher A; Chilosi M; Bonetti F
Am J Clin Pathol; 2009 May; 131(5):678-82. PubMed ID: 19369627
[TBL] [Abstract][Full Text] [Related]
22. Heterogeneity assessment of histological tissue sections in whole slide images.
Belhomme P; Toralba S; Plancoulaine B; Oger M; Gurcan MN; Bor-Angelier C
Comput Med Imaging Graph; 2015 Jun; 42():51-5. PubMed ID: 25475487
[TBL] [Abstract][Full Text] [Related]
23. Prognostic Significance of Lacunarity in Preoperative Biopsy of Colorectal Cancer.
Aralica G; Šarec Ivelj M; Pačić A; Baković J; Milković Periša M; Krištić A; Konjevoda P
Pathol Oncol Res; 2020 Oct; 26(4):2567-2576. PubMed ID: 32617959
[TBL] [Abstract][Full Text] [Related]
24. Multilevel analysis of spatiotemporal association features for differentiation of tumor enhancement patterns in breast DCE-MRI.
Lee SH; Kim JH; Cho N; Park JS; Yang Z; Jung YS; Moon WK
Med Phys; 2010 Aug; 37(8):3940-56. PubMed ID: 20879557
[TBL] [Abstract][Full Text] [Related]
25. Intratumoral heterogeneity in colorectal carcinoma: trucut sampling for DNA ploidy analysis.
Giovagnoli MR; Giarnieri E; Midiri G; Tesoriere A; Ferraro S; Vecchione A
Anticancer Res; 1999; 19(5C):4577-80. PubMed ID: 10650813
[TBL] [Abstract][Full Text] [Related]
26. Digital Pathology Analysis Quantifies Spatial Heterogeneity of CD3, CD4, CD8, CD20, and FoxP3 Immune Markers in Triple-Negative Breast Cancer.
Mi H; Gong C; Sulam J; Fertig EJ; Szalay AS; Jaffee EM; Stearns V; Emens LA; Cimino-Mathews AM; Popel AS
Front Physiol; 2020; 11():583333. PubMed ID: 33192595
[TBL] [Abstract][Full Text] [Related]
27. Digital imaging in the immunohistochemical evaluation of the proliferation markers Ki67, MCM2 and Geminin, in early breast cancer, and their putative prognostic value.
Joshi S; Watkins J; Gazinska P; Brown JP; Gillett CE; Grigoriadis A; Pinder SE
BMC Cancer; 2015 Jul; 15():546. PubMed ID: 26205655
[TBL] [Abstract][Full Text] [Related]
28. Enhanced resting-state dynamics of the hemoglobin signal as a novel biomarker for detection of breast cancer.
Graber HL; Al abdi R; Xu Y; Asarian AP; Pappas PJ; Dresner L; Patel N; Jagarlamundi K; Solomon WB; Barbour RL
Med Phys; 2015 Nov; 42(11):6406-24. PubMed ID: 26520731
[TBL] [Abstract][Full Text] [Related]
29. Uncovering Spatiotemporal Heterogeneity of High-Grade Gliomas: From Disease Biology to Therapeutic Implications.
Comba A; Faisal SM; Varela ML; Hollon T; Al-Holou WN; Umemura Y; Nunez FJ; Motsch S; Castro MG; Lowenstein PR
Front Oncol; 2021; 11():703764. PubMed ID: 34422657
[TBL] [Abstract][Full Text] [Related]
30. Exploring the spatial dimension of estrogen and progesterone signaling: detection of nuclear labeling in lobular epithelial cells in normal mammary glands adjacent to breast cancer.
Grote A; Abbas M; Linder N; Kreipe HH; Lundin J; Feuerhake F
Diagn Pathol; 2014; 9 Suppl 1(Suppl 1):S11. PubMed ID: 25565114
[TBL] [Abstract][Full Text] [Related]
31. Metabolic mapping of gliomas using hybrid MR-PET imaging: feasibility of the method and spatial distribution of metabolic changes.
Bisdas S; Ritz R; Bender B; Braun C; Pfannenberg C; Reimold M; Naegele T; Ernemann U
Invest Radiol; 2013 May; 48(5):295-301. PubMed ID: 23296081
[TBL] [Abstract][Full Text] [Related]
32. Intratumoral patterns of clonal evolution in meningiomas as defined by multicolor interphase fluorescence in situ hybridization (FISH): is there a relationship between histopathologically benign and atypical/anaplastic lesions?
Sayagués JM; Tabernero MD; Maíllo A; Espinosa A; Rasillo A; Díaz P; Ciudad J; López A; Merino M; Gonçalves JM; Santos-Briz A; Morales F; Orfao A
J Mol Diagn; 2004 Nov; 6(4):316-25. PubMed ID: 15507670
[TBL] [Abstract][Full Text] [Related]
33. ADC texture--an imaging biomarker for high-grade glioma?
Brynolfsson P; Nilsson D; Henriksson R; Hauksson J; Karlsson M; Garpebring A; Birgander R; Trygg J; Nyholm T; Asklund T
Med Phys; 2014 Oct; 41(10):101903. PubMed ID: 25281955
[TBL] [Abstract][Full Text] [Related]
34. Machine learning approaches to analyze histological images of tissues from radical prostatectomies.
Gertych A; Ing N; Ma Z; Fuchs TJ; Salman S; Mohanty S; Bhele S; Velásquez-Vacca A; Amin MB; Knudsen BS
Comput Med Imaging Graph; 2015 Dec; 46 Pt 2(Pt 2):197-208. PubMed ID: 26362074
[TBL] [Abstract][Full Text] [Related]
35. Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma.
Abdulrauf SI; Edvardsen K; Ho KL; Yang XY; Rock JP; Rosenblum ML
J Neurosurg; 1998 Mar; 88(3):513-20. PubMed ID: 9488306
[TBL] [Abstract][Full Text] [Related]
36. Tumor heterogeneity: mechanisms and bases for a reliable application of molecular marker design.
Diaz-Cano SJ
Int J Mol Sci; 2012; 13(2):1951-2011. PubMed ID: 22408433
[TBL] [Abstract][Full Text] [Related]
37. Phosphotyrosine signaling analysis in human tumors is confounded by systemic ischemia-driven artifacts and intra-specimen heterogeneity.
Gajadhar AS; Johnson H; Slebos RJ; Shaddox K; Wiles K; Washington MK; Herline AJ; Levine DA; Liebler DC; White FM;
Cancer Res; 2015 Apr; 75(7):1495-503. PubMed ID: 25670172
[TBL] [Abstract][Full Text] [Related]
38. Automated Analysis of Proliferating Cells Spatial Organisation Predicts Prognosis in Lung Neuroendocrine Neoplasms.
Bulloni M; Sandrini G; Stacchiotti I; Barberis M; Calabrese F; Carvalho L; Fontanini G; Alì G; Fortarezza F; Hofman P; Hofman V; Kern I; Maiorano E; Maragliano R; Marchiori D; Metovic J; Papotti M; Pezzuto F; Pisa E; Remmelink M; Serio G; Marzullo A; Trabucco SMR; Pennella A; De Palma A; Marulli G; Fassina A; Maffeis V; Nesi G; Naheed S; Rea F; Ottensmeier CH; Sessa F; Uccella S; Pelosi G; Pattini L
Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638359
[TBL] [Abstract][Full Text] [Related]
39. Spatial heterogeneity of cancer associated protein expression in immunohistochemically stained images as an improved prognostic biomarker.
Failmezger H; Hessel H; Kapil A; Schmidt G; Harder N
Front Oncol; 2022; 12():964716. PubMed ID: 36601480
[TBL] [Abstract][Full Text] [Related]
40. An effective method to verify line and point spread functions measured in computed tomography.
Ohkubo M; Wada S; Matsumoto T; Nishizawa K
Med Phys; 2006 Aug; 33(8):2757-64. PubMed ID: 16964851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
